Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Clofutriben by Sparrow Pharmaceuticals for Cushing's Syndrome: Likelihood of Approval
Clofutriben is under clinical development by Sparrow Pharmaceuticals and currently in Phase II for Cushing's Syndrome. According to GlobalData, Phase...
Data Insights
Clofutriben by Sparrow Pharmaceuticals for Adrenocortical Hyperfunction: Likelihood of Approval
Clofutriben is under clinical development by Sparrow Pharmaceuticals and currently in Phase II for Adrenocortical Hyperfunction. According to GlobalData, Phase...